Physician profile

Rohan Sharma

Hematology & Oncology · Scottsdale, AZ

NPI 1053686394

$12,659.60

in general payments reported to CMS, 2019-2025

38 companies · $65.44 in 2025

The $65.44 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$3,235.00
Food and Beverage$427.81
Education$21.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $4,491.49 2019-2024 Imfinzi
Jazz Pharmaceuticals INC. $2,206.72 2020
Beigene USA, INC. $1,938.39 2020-2024 Brukinsa
Taiho Oncology, INC. $1,087.50 2020
Daiichi Sankyo INC. $992.07 2019
Novocure Gmbh $250.00 2022
E.R. Squibb & Sons, L.L.C. $224.41 2019-2022
Icotec Medical INC. $170.26 2022-2023 Icotec Blackarmor Spine System
Progenics Pharmaceuticals, INC. $122.13 2023 Pylarify
Seagen INC. $119.75 2021
Rigel Pharmaceuticals, INC. $85.61 2019-2020
Genzyme Corporation $84.70 2019
Lilly USA, LLC $77.28 2019
Novartis Pharmaceuticals Corporation $64.51 2019
Pharmacyclics LLC, An Abbvie Company $62.77 2019-2023 Epkinly, Imbruvica
Show all 38 companies
CompanyGeneral paymentsYearsTop products
Pfizer INC. $61.97 2019
Janssen Biotech, INC. $58.72 2019-2023 Erleada
Davol INC. $50.38 2025 Progel Applicator Spray Tips
Intuitive Surgical, INC. $48.80 2024
Bayer Healthcare Pharmaceuticals INC. $47.54 2019
Celgene Corporation $43.71 2019-2020
Amgen INC. $41.45 2019
Genentech USA, INC. $35.22 2019-2020
Incyte Corporation $33.11 2019
Boehringer Ingelheim Pharmaceuticals, INC. $31.53 2019
Verastem, INC. $23.08 2019
Agios Pharmaceuticals, INC. $22.28 2019
Kyowa Kirin, INC. $22.03 2019
Mirati Therapeutics, INC. $21.00 2023 Krazati
Ipsen Biopharmaceuticals, INC $20.92 2020
Eisai INC. $20.29 2019
Helsinn Therapeutics (U.S.), INC. $17.36 2019
Lexicon Pharmaceuticals, INC. $16.21 2019
Abbvie INC. $15.06 2025
Emd Serono, INC. $14.04 2019
Mylan Institutional INC. $13.95 2019
Gilead Sciences, INC. $11.92 2021
Astellas Pharma US INC $11.44 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Rohan Sharma

$12,659.60

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $65.44 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).

https://glasscript.com/doctor/1380903/rohan-sharma

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.